An NDA was granted for an oncology drug for use in the Chinese market.

2 reports, 1 independent Updated Jul 2

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

An NDA was granted for an oncology drug for use in the Chinese market.

Who's involved

What this event is mainly about

China American Society of Clinical Oncology

Keep exploring

Part of

Chinese biopharma is gaining ground, producing oncology drugs that rival established Western pharmaceuticals like those associated with Merck.

Also in this story

LG Chem and OTR Therapeutics announce a strategic collaboration to leverage China's life science ecosystem for oncology R&D.Jul 8

All 4 developments

The entities involved

China
cultural region, ancient civilization, and nation in East Asia; mostly refers to the People's Republic of China in political situation and rarely refers to the Republic of China
- The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49
- The Middle Corridor, linking Central Asia and Europe, is gaining significance in regional trade and energy routes.Mon 17:06
American Society of Clinical Oncology
organization

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jul 2manilatimes.net

1 more outlet ran the same wire story

Jul 1investegate.co.uk